Showing results (431-440 of 764) with videos related to
Sort By:
Pageof 77
Pediatrics|February 1, 1981
Depressed neutrophil chemotaxis in infants with cow's milk and/or soy protein intoleranceH L Butler, W J Byrne, D J Marmer, et al.The American Journal of Cardiology|October 1, 1981
Digoxin-induced positive exercise tests: their clinical and prognostic significanceM H Sketch, A N Mooss, M L Butler, et al.Tissue Engineering|May 24, 2007
Mechanical stimulation increases collagen type I and collagen type III gene expression of stem cell-collagen sponge constructs for patellar tendon repairNatalia Juncosa-Melvin, Karl S Matlin, Robert W Holdcraft, et al.Poultry Science|August 31, 2018
The effects of floor space and nest box access on the physiology and behavior of caged laying hensJ M Engel, T M Widowski, A J Tilbrook, et al.Plos Pathogens|November 13, 2012
Structural and functional insights into the HIV-1 maturation inhibitor binding pocketKayoko Waki, Stewart R Durell, Ferri Soheilian, et al.Journal of Biomechanical Engineering|May 1, 1983
Error analysis of a system for measuring three-dimensional joint motionW J Suntay, E S Grood, M S Hefzy, et al.Molecular Ecology Resources|August 18, 2021
Transposable element annotation in non-model species: The benefits of species-specific repeat libraries using semi-automated EDTA and DeepTE de novo pipelinesEllen A Bell, Christopher L Butler, Claudio Oliveira, et al.Organic Letters|July 14, 2006
Anion binding to monotopic and ditopic macrocyclic amidesIvan V Korendovych, Mimi Cho, Phillip L Butler, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 11, 2002
A potential mechanism for age-related declines in patellar tendon biomechanicsM R Dressler, D L Butler, R Wenstrup, et al.Antimicrobial Agents and Chemotherapy|September 9, 2025
Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3)Nicole E Scangarella-Oman, Deborah L Butler, John Breton, et al.Pageof 77